Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Uterine Diseases × selinexor × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Recurrence 4 Neoplasms 2 Leukemia, Myeloid, Acute 2 Uterine Neoplasms 1 Uterine Diseases 1 Primary Myelofibrosis 1 Neoplasms by Site 1 Myeloproliferative Disorders 1 Lymphoma, Large B-Cell, Diffuse 1 Genital Diseases 1 Endometrial Neoplasms 1 COVID-19 1

Interventions

selinexor 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03555422 2025-01-20

ENGOT-EN5

Karyopharm Therapeutics Inc

Phase 3 Active not recruiting

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡